Sandra Cascio, PhD

  • Assistant Professor, Department of Obstetrics, Gynecology and Reproductive Sciences
  • Member, Cancer Immunology and Immunotherapy Program, Hillman Cancer Center
  • Director, College Summer Internship Program at MWRI

Education & Training

  • BS in Molecular and Cellular Biology, University of Palermo
  • PhD in Molecular Oncology, University of Palermo
  • Postdoctoral and Research Fellow, Department of Immunology, University of Pittsburgh

Research Interest Summary

Tumor Immunology, Basic Immunological Mechanisms, Molecular Basis of Cancer

Research Interests

My laboratory investigates the intercellular communications between stroma, tumor cells and immune cells within the tumor microenvironment. I am particularly focused on gaining a better understanding of how factors, secreted by stromal and tumor cells, modulate the immunosuppressive activities of tumor-associated myeloid cells, driving resistance to immunotherapies. Using mouse models of ovarian cancer and clinical samples, my long-term goal is to identify novel therapeutical approaches to enhance anti-tumor immunity.

Publications

1)   L Zhang#, S Cascio#, C Adams, J W Mellors, R J Buckanovich, H U Osmanbeyoglu. Singlecell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. (#Contributed equally). Communications Biology; 2024 Jan 5;7(1):20. doi: 10.1038/s42003-023-05733-x.

2)   Cascio S, Chandler C, Zhang L, Sinno S, Gao B, Onkar S, Bruno TC, Vignali DAA, Mahdi H, Osmanbeyoglu HU, Vlad AM, Coffman LG, Buckanovich RJ. Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition. Sci Adv. 2021 Nov 12;7(46):eabi5790. doi: 10.1126/sciadv.abi5790. Epub 2021 Nov 12. PMID: 34767446

3)   Kvorjak M, Ahmed Y, Miller LM, Sriram R, Coronello C, Hashash GJ, Hartman JD, Telmer AC, Miskov-Zinavov N, Finn JO and Cascio S. Crosstalk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer. Cancer Immunology Research. 2020 Feb;8(2):167-178. doi: 10.1158/2326-6066.

4)   Cascio S, Faylo JL, Sciurba JC, Xu J, Ranganathan S, Lohmueller JJ, Beatty PL and Finn OJ. Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-kB p65 and EzH2, in colitis-associated cancer. Oncotarget. 2017 https://doi.org/10.18632/oncotarget.22168

5)   Cascio S, Medsger TA Jr, Hawse WF, Watkins SC, Milcarek C, Moreland LW, Lafyatis RA, Fuschiotti P. 14-3-3z sequesters cytosolic T-bet, up-regulating IL-13 in Tc2 and scleroderma CD8+ lymphocytes. J Allergy Clin Immunol. 2017 Nov 15. pii: S0091-6749(17)31760-8. doi: 10.1016/j.jaci.2017.10.029

Complete list of publications